Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.7045
+0.0186 (2.70%)
At close: Aug 1, 2025, 4:00 PM
0.7084
+0.0040 (0.56%)
After-hours: Aug 1, 2025, 6:22 PM EDT
Model N Market Cap
Trinity Biotech has a market cap or net worth of $13.08 million as of August 1, 2025. Its market cap has decreased by -51.00% in one year.
Market Cap
13.08M
Enterprise Value
108.68M
1-Year Change
-51.00%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $44.82M to $13.08M, a decrease of -70.82%. That is a compound annual growth rate of -4.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 12.73M | -16.97% |
| Dec 31, 2024 | 15.34M | -6.42% |
| Dec 29, 2023 | 16.39M | -56.55% |
| Dec 30, 2022 | 37.73M | 26.22% |
| Dec 31, 2021 | 29.89M | -62.47% |
| Dec 31, 2020 | 79.64M | 268.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |